ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021 Jun 2, 2021
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq Jun 2, 2021
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq May 27, 2021
ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health Apr 26, 2021
ZIVO Bioscience to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference Mar 11, 2021
ZIVO Bioscience Successfully Confirms Poultry Growth Promotion and Feed Conversion Ratio Improvements in Typical Production Environments Jan 11, 2021
ZIVO Bioscience Receives Notice of Allowance for Cytokine Modulation Patent Application From US Patent Office, Commences Bioproduct Scaleup Jun 9, 2020
